Stay updated on GSK2857916 Dose Escalation Clinical Trial
Sign up to get notified when there's something new on the GSK2857916 Dose Escalation Clinical Trial page.

Latest updates to the GSK2857916 Dose Escalation Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedCore page content updated to include a funding-status notice and operating-status guidance, plus a version upgrade from v3.1.0 to v3.2.0.SummaryDifference0.9%
- Check21 days agoChange Detected- Updated medical term from 'Plasma cell myeloma' to 'Multiple myeloma'. - Page revision bumped from v3.0.2 to v3.1.0.SummaryDifference0.1%
- Check28 days agoChange DetectedAdded a MedlinePlus Genetics topic covering multiple myeloma, expanding core medical content.SummaryDifference0.1%
- Check35 days agoChange DetectedAdded a new release tag v3.0.2 and removed the MedlinePlus Genetics topic on Multiple myeloma, along with the older revision note (v3.0.1) and the Back to Top link.SummaryDifference0.1%
- Check42 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.1%
- Check49 days agoChange DetectedThe web page has been updated to include a new facility name and location, as well as specific medical information regarding plasma cell myeloma and the drug belantamab mafodotin. Additionally, a new version revision has been noted.SummaryDifference0.9%
Stay in the know with updates to GSK2857916 Dose Escalation Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GSK2857916 Dose Escalation Clinical Trial page.